Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Accounts Payables (2016 - 2025)

Sanofi's Accounts Payables history spans 17 years, with the latest figure at $8.6 billion for Q4 2025.

  • On a quarterly basis, Accounts Payables rose 6.19% to $8.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $8.6 billion, a 6.19% increase, with the full-year FY2025 number at $8.6 billion, up 6.19% from a year prior.
  • Accounts Payables hit $8.6 billion in Q4 2025 for Sanofi, up from $8.0 billion in the prior quarter.
  • Over the last five years, Accounts Payables for SNY hit a ceiling of $8.6 billion in Q4 2025 and a floor of $6.5 billion in Q2 2021.
  • Historically, Accounts Payables has averaged $7.6 billion across 5 years, with a median of $7.9 billion in 2023.
  • Biggest five-year swings in Accounts Payables: rose 19.42% in 2021 and later decreased 1.68% in 2022.
  • Tracing SNY's Accounts Payables over 5 years: stood at $7.1 billion in 2021, then dropped by 1.68% to $7.0 billion in 2022, then increased by 13.43% to $7.9 billion in 2023, then grew by 2.34% to $8.1 billion in 2024, then grew by 6.19% to $8.6 billion in 2025.
  • Business Quant data shows Accounts Payables for SNY at $8.6 billion in Q4 2025, $8.0 billion in Q2 2025, and $8.1 billion in Q4 2024.